References
- Fredheim OMS, Moksnes K, Borchgrevink PC, et al. Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand. 2008;52:879–889.
- Lee S, Klein-Schwartz W, Welsh C, et al. Medical outcomes associated with nonmedical use of methadone and buprenorphine. J Emerg Med. 2013;45:199–205.
- Boyer EW, McCance-Katz EF, Marcus S. Methadone and buprenorphine toxicity in children. Am J Addict. 2010;19:89–95.
- Fung HT, Cheung KH, Lam SK, et al. A case of unintentional methadone overdose followed by hypoglycaemia. Hong Kong J Emerg Med. 2011;18:239–242.
- Li ATY, Chu FKC. A case of massive methadone overdose presented with refractory hypoglycemia. Clin Toxicol. 2017;55:233–233.
- Gjedsted J, Dall R. Severe hypoglycemia during methadone escalation in an 8-year-old child. Acta Anaesthesiol Scand. 2015;59:1394–1396.
- Moryl N, Pope J, Obbens E. Hypoglycemia during rapid methadone dose escalation. J Opioid Manag. 2013;9:29–34.
- Flory JH, Wiesenthal AC, Thaler HT, et al. Methadone use and the risk of hypoglycemia for inpatients with cancer pain. J Pain Symptom Manage. 2016;51:79–87.e1.
- Faskowitz AJ, Kramskiy VN, Pasternak GW. Methadone-induced hypoglycemia. Cell Mol Neurobiol. 2013;33:537–542.
- Amirshahrokhi K, Dehpour AR, Hadjati J, et al. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicol Appl Pharmacol. 2008;232:119–124.
- Kanter RA, Ensinck JW, Fujimoto WY. Disparate effects of enkephalin and morphine upon insulin and glucagon secretion by islet cell cultures. Diabetes. 1980;29:84–86.
- Brvar M, Mozina M, Bunc M. Prolonged hypoglycaemia after insulin lispro overdose. Eur J Emerg Med. 2005;12:234–235.
- Mork TA, Killeen CT, Patel NK, et al. Massive insulin overdose managed by monitoring daily insulin levels. Am J Ther. 2011;18:e162–e166.